Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
Constantin N. Baxevanis
Cancers (2023) Vol. 15, Iss. 3, pp. 881-881
Open Access | Times Cited: 10

Showing 10 citing articles:

Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 10
Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer
Ion Petre, Corina Vernic, Izabella Petre, et al.
Diseases (2024) Vol. 12, Iss. 4, pp. 77-77
Open Access | Times Cited: 5
Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy
Irina Naletova, Barbara Tomasello, Francesco Attanasio, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1346-1346
Open Access | Times Cited: 12
Advancing Precision Medicine: Uncovering Biomarkers and Strategies to Mitigate Immune-Related Adverse Events in Immune Checkpoint Inhibitors Therapy
K L Nityashree, P. Rachitha, Shilpa Hanchinmane, et al.
Toxicology Reports (2025), pp. 102035-102035
Open Access
Perimyocarditis Associated with Immune Checkpoint Inhibitors: A Case Report and Review of the Literature
Walid Shalata, Rachel Steckbeck, Amjad Abu Salman, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 224-224
Open Access | Times Cited: 2
Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review
Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 4
The Intestinal Microbiota and Therapeutic Responses to Immunotherapy
Pamela S. Herrera, Marcel R.M. van den Brink
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 435-452
Closed Access | Times Cited: 1
TGF-β trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance
Tony R. Reid, Bryan Oronsky, J. E. Williams, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009613-e009613
Open Access | Times Cited: 1
Non-viral vector-based genome editing for cancer immunotherapy
Tianxu Fang, Guojun Chen
Biomaterials Science (2024) Vol. 12, Iss. 12, pp. 3068-3085
Closed Access
Oncolytic Virus: A Promising Immunotherapy to Treat Tumors
Anthony Rosen
Science Insights (2023) Vol. 42, Iss. 2, pp. 801-805
Open Access
Page 1

Scroll to top